FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Implantable Cardioverter Defibrillator (Non-Crt)
PMA: P950022
·
Supplement: S134
·
Decision Jun 30, 2020
Classifications
1
FEI Numbers
49
Registration Numbers
49
Basic Information
- Device Name
- Implantable Cardioverter Defibrillator (Non-Crt)
- Trade Name
- Durata And Optisure HV Passive Steroid Eluting Cardiac Leads
- PMA Number
- P950022
- Supplement Number
- S134
- Device Class
- FDA Class 3
- Product Code
- LWS
- Generic Name
- Implantable cardioverter defibrillator (non-CRT)
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- June 30, 2020
- Date Received
- June 1, 2020
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Implement previously approved changes to new lead models Durata (7172Q) and Optisure (LDP210Q).
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LWS | Implantable Cardioverter Defibrillator (Non-Crt) | FDA class 3 | Unknown |